Search
for
Sort by
Research 91–120 of 710
- Biocompatible nanoparticles and vesicular systems in transdermal drug delivery for various skin diseases
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- ‘Disappearing Foot Disease’: An Unusual Presentation of Primary Lymphoma of Bone
- Frequency and associated factors of hair loss among patients with inflammatory bowel disease
- Significant Correction of Disease after Postnatal Administration of Recombinant Ectodysplasin A in Canine X-Linked Ectodermal Dysplasia
- Suspected upadacitinib-associated drug hypersensitivity mimicking disease exacerbation in ulcerative colitis
- Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment
- The Use of Adipose-Derived Stem Cells in Selected Skin Diseases (Vitiligo, Alopecia, and Nonhealing Wounds)
- De novo single-nucleotide and copy number variation in discordant monozygotic twins reveals disease-related genes
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Repositioning Old Drugs for New Battles: The Expanding Role of Drug Repurposing in Cancer, Inflammation, and Metabolic Disease.
- Risk Factors for the Development of and Outcomes After Diagnosis of Autoimmune Alopecia Areata in Patients with Inflammatory Bowel Diseases
- Scleroderma and L-tryptophan: A possible explanation of the eosinophilia-myalgia syndrome
- Clinical features of vitiligo associated with comorbid autoimmune disease: A prospective survey
- Pyodermatitis vegetans associated with multiple myeloma
- Effects of Selenium and Other Micronutrient Intake on Human Health
- The role of diet in the management of psoriasis: a scoping review
- Celiac Disease: Beyond Diet and Food Awareness
- Alopecia Areata
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
- Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
- What causes hidradenitis suppurativa ?—15 years after
- The analysis of genetics and associated autoimmune diseases in Chinese vitiligo patients
- The Role of Nutrition in Immune-Mediated, Inflammatory Skin Disease: A Narrative Review
- Pemphigus and associated comorbidities: a cross-sectional study
- Dermatological symptoms and sexual abuse: a review and case reports
- Bioengineered Skin Intended as In Vitro Model for Pharmacosmetics, Skin Disease Study and Environmental Skin Impact Analysis
- Medical comorbidities in patients with lichen planopilaris, a retrospective case–control study
- Cardiovascular Disease-Associated Skin Conditions
- Immune-Molecular Link between Thyroid and Skin Autoimmune Diseases: A Narrative Review